View the LENVIDX registration information details.
Back to drug list
ItemsDrug Registration information
ID238
No238
Brand NameLENVIDX
IngredientsLENVATINIB 10 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 30'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
Indications TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE- BLUE CAPSULES
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No07 L 1156/24
FDD Registration Date07/08/2024
Expiry Date06/08/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA